Human papillomavirus in the era of highly active antiretroviral therapy for human immunodeficiency virus: An immune reconstitution-associated disease?

British Journal of Dermatology

Volumn 162, Issue 1, 2010, Pages 6-11

  Meys, R ^a   Gotch, F M ^a   Bunker, C B ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

HAART; HIV; HPV; Immune reconstitution disease; IRD

Indexed keywords

CANCER RISK; CONDYLOMA ACUMINATUM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DYSREGULATION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; NONHUMAN; PENIS CANCER; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER; VAGINA CANCER; VULVA CANCER; WART VIRUS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; TERMINOLOGY AS TOPIC; WARTS;

EID: 72749083662     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09365.x     Document Type: Review

References (52)

1. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006 57 : 167 170.
2. Choremis CB, Padiatellis C, Zou Mbou Lakis D, Yannakos D. Transitory exacerbation of fever and roentgenographic findings during treatment of tuberculosis in children. Am Rev Tuberc 1955 72 : 527 536.
3. French MA, Mallal SA, Dawkins RL. Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients. AIDS 1992 6 : 1293 1297.
4. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004 18 : 1615 1627.
5. Carpenter CC, Fischl MA, Hammer SM et al. Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society, USA. JAMA 1996 276 : 146 154.
6. French MA, Lenzo N, John M et al. Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000 1 : 107 115.
7. Lehloenya R, Meintjes G. Dermatologic manifestations of the immune reconstitution inflammatory syndrome. Dermatol Clin 2006 24 : 549 570, vii.
8. Manabe YC, Campbell JD, Sydnor E et al. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007 46 : 456 462.
9. French MA. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009 48 : 101 107.
10. Dhasmana DJ, Dheda K, Ravn P et al. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs 2008 68 : 191 208.
11. Robertson J, Meier M, Wall J et al. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis 2006 42 : 1639 1646.
12. French MA, Colebunders R. Immune restoration disease. Curr Opin HIV AIDS 2008 3 : 417 418.
13. Lipman M, Breen R. Immune reconstitution inflammatory syndrome in HIV. Curr Opin Infect Dis 2006 19 : 20 5.
14. Fox PA, Barton SE, Francis N et al. Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV Med 1999 1 : 10 18.
15. Greenspan D, Canchola AJ, MacPhail LA et al. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001 357 : 1411 1412.
16. Huiras E, Preda V, Maurer T et al. Cutaneous manifestations of immune reconstitution inflammatory syndrome. Curr Opin HIV AIDS 2008 3 : 453 460.
17. Price P, Mathiot N, Krueger R et al. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol 2001 22 : 279 287. (Pubitemid 32846559)
18. Cooney EL. Clinical indicators of immune restoration following highly active antiretroviral therapy. Clin Infect Dis 2002 34 : 224 233.
19. Price P, Keane NM, Stone SF et al. MHC haplotypes affect the expression of opportunistic infections in HIV patients. Hum Immunol 2001 62 : 157 164.
20. Price P, Witt C, de Santis D, French MA. Killer immunoglobulin-like receptor genotype may distinguish immunodeficient HIV-infected patients resistant to immune restoration diseases associated with herpes virus infections. J Acquir Immune Defic Syndr 2007 45 : 359 361.
21. Bunker CB, Gotch FM. HIV and the skin. In : Rook's Textbook of Dermatology (Burns D, Breathnach S, Cox N, Griffiths C, eds 8th edn. Oxford : Blackwell Publishing, 2009.
22. de Villiers EM. Prevalence of HPV 7 papillomas in the oral mucosa and facial skin of patients with human immunodeficiency virus. Arch Dermatol 1989 125 : 1590.
23. Porro AM, Alchorne MM, Mota GR et al. Detection and typing of human papillomavirus in cutaneous warts of patients infected with human immunodeficiency virus type 1. Br J Dermatol 2003 149 : 1192 1199.
24. Barzegar C, Paul C, Saiag P et al. Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection. Br J Dermatol 1998 139 : 122 127.
25. Davison SC, Francis N, McLean K et al. Epidermodysplasia verruciformis-like eruption associated with HIV infection. Clin Exp Dermatol 2004 29 : 311 312.
26. Berger TG, Sawchuk WS, Leonardi C et al. Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease. Br J Dermatol 1991 124 : 79 83.
27. Cavalcanti SM, Deus FC, Oliveira LH. Unusual HPV types in cutaneous warts in association with immunological deficiency. Mem Inst Oswaldo Cruz 1998 93 : 433 434.
28. Rudlinger R, Grob R. Papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989 1 : 1132 1133.
29. Van der Leest RJ, Zachow KR, Ostrow RS et al. Human papillomavirus heterogeneity in 36 renal transplant recipients. Arch Dermatol 1987 123 : 354 357.
30. Palefsky JM, Holly EA. Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2003 6 : 41 6.
31. Harwood CA, Proby CM. Human papillomavirus and immunosuppression. In : Human Papillomaviruses: Clinical and Scientific Advances (Sterling JC, Tyring SK, eds). London : Arnold, 2001 102 117.
32. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005 32 (Suppl. 1 S7 15.
33. de Sanjose S, Palefsky J. Cervical and anal HPV infections in HIV positive women and men. Virus Res 2002 89 : 201 211.
34. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002 35 : 1127 1134.
35. Palefsky JM, Gillison ML, Strickler HD. HPV vaccines in immunocompromised women and men. Vaccine 2006 24 (Suppl. 3 S140 6.
36. Porter WM, Francis N, Hawkins D et al. Penile intraepithelial neoplasia: clinical spectrum and treatment of 35 cases. Br J Dermatol 2002 147 : 1159 1165.
37. International Agency for Research on Cancer. Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Geneva : WHO Press, 2007.
38. Massad LS, Silverberg MJ, Springer G et al. Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol 2004 190 : 1241 1248.
39. Kreuter A, Brockmeyer NH, Altmeyer P et al. Anal intraepithelial neoplasia in HIV infection. J Dtsch Dermatol Ges 2008 6 : 925 934.
40. Palefsky JM, Holly EA, Efirdc JT et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005 19 : 1407 1414.
41. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000 92 : 1500 1510.
42. Maurer T, Rodrigues LK, Ameli N et al. The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women. Clin Infect Dis 2004 38 : 579 584.
43. Dolev JC, Maurer T, Springer G et al. Incidence and risk factors for verrucae in women. AIDS 2008 22 : 1213 1219.
44. Rodrigues LK, Baker T, Maurer T. Cutaneous warts in HIV-positive patients undergoing highly active antiretroviral therapy. Arch Dermatol 2001 137 : 1103 1104.
45. Greenwood I, Zakrzewska JM, Robinson PG. Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years. Oral Dis 2002 8 : 90 4.
46. Patton LL, McKaig R, Strauss R et al. Changing prevalence of oral manifestations of human immunodeficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 89 : 299 304.
47. Fox PA. Human papillomavirus and anal intraepithelial neoplasia. Curr Opin Infect Dis 2006 19 : 62 6.
48. Heard I, Palefsky JM, Kazatchkine MD. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004 9 : 13 22.
49. Moussa R, Stephenson I, Fisk P et al. Buschke-Loewenstein lesion: another possible manifestation of immune restoration inflammatory syndrome? AIDS 2004 18 : 1221 1223.
50. King MD, Reznik DA, O'Daniels CM et al. Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis 2002 34 : 641 648.
51. Cameron JE, Mercante D, O'Brien M et al. The impact of highly active antiretroviral therapy and immunodeficiency on human papillomavirus infection of the oral cavity of human immunodeficiency virus-seropositive adults. Sex Transm Dis 2005 32 : 703 709.
52. Maurer T, Ponte M, Leslie K. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med 2007 357 : 1352 1353.